(BTI) British American Tobacco - Ratings and Ratios
Exchange: NYSE • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US1104481072
BTI EPS (Earnings per Share)
BTI Revenue
BTI: Vapour Products, Heated Products, Combustible Cigarettes, Oral Products
British American Tobacco p.l.c. is a multinational tobacco company operating globally, with a diverse portfolio of tobacco and nicotine products. The companys product range includes vapour, heated, and modern oral nicotine products, as well as combustible cigarettes and traditional oral products like snus and moist snuff, marketed under well-known brands such as Vuse, glo, and Camel. With a presence in over 180 markets, the company has established a significant global footprint.
From a business perspective, British American Tobacco p.l.c. has demonstrated its ability to adapt to changing market conditions, driven by increasing regulatory pressures and shifting consumer preferences. The companys focus on innovation, particularly in the areas of vapour and heated tobacco products, is a strategic response to declining combustible cigarette sales in many markets. This diversification effort is expected to continue, with the company investing in next-generation products.
Analyzing the
Based on the provided data, a forecast for British American Tobacco p.l.c. (NYSE:BTI) could involve the following: Given the current price is near its 52-week high, and considering the support levels at $42.1, $41.0, $36.3, and $35.6, a potential short-term target could be a continued test of its recent highs, with potential resistance at $45.26. However, a break below $42.1 could signal a downward trend towards the lower support levels. The relatively low forward P/E ratio compared to its current P/E suggests that the company may be undervalued in the markets future earnings expectations, potentially indicating a buying opportunity for investors with a longer-term perspective.
Additional Sources for BTI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BTI Stock Overview
Market Cap in USD | 105,545m |
Sector | Consumer Defensive |
Industry | Tobacco |
GiC Sub-Industry | Tobacco |
IPO / Inception | 1980-04-14 |
BTI Stock Ratings
Growth Rating | 63.9 |
Fundamental | 3.39 |
Dividend Rating | 79.0 |
Rel. Strength | 42.6 |
Analysts | 3.4 of 5 |
Fair Price Momentum | 55.46 USD |
Fair Price DCF | 191.44 USD |
BTI Dividends
Dividend Yield 12m | 10.84% |
Yield on Cost 5y | 17.37% |
Annual Growth 5y | 1.88% |
Payout Consistency | 88.9% |
Payout Ratio | 171.3% |
BTI Growth Ratios
Growth Correlation 3m | 89.8% |
Growth Correlation 12m | 92% |
Growth Correlation 5y | 62% |
CAGR 5y | 12.71% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | 2.58 |
Alpha | 59.16 |
Beta | 0.035 |
Volatility | 19.81% |
Current Volume | 6885.1k |
Average Volume 20d | 6820.5k |
As of June 30, 2025, the stock is trading at USD 46.96 with a total of 6,885,079 shares traded.
Over the past week, the price has changed by -2.17%, over one month by +6.08%, over three months by +15.31% and over the past year by +62.74%.
Neither. Based on ValueRay´s Fundamental Analyses, British American Tobacco is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.39 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BTI is around 55.46 USD . This means that BTI is currently undervalued and has a potential upside of +18.1% (Margin of Safety).
British American Tobacco has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold BTI.
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 1
According to our own proprietary Forecast Model, BTI British American Tobacco will be worth about 59.9 in June 2026. The stock is currently trading at 46.96. This means that the stock has a potential upside of +27.56%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 46.9 | -0.1% |
Analysts Target Price | 46.4 | -1.2% |
ValueRay Target Price | 59.9 | 27.6% |